Respiratory Disease
Showing of 6 results
UH Rainbow Babies & Children’s Hospital Awarded $1 Million in PCORI Funding to Improve Antibiotic Prescribing for Childhood Respiratory Infections
Award from the Patient-Centered Outcomes Research Institute aims to expand the successful inpatient pediatric antimicrobial stewardship program that UH Rainbow launched in 2013.
Researchers awarded $2.8M federal grant to study potential treatment of Sudden Infant Death Syndrome
Using a model they developed that mimics conditions associated with most SIDS cases, researchers hope the federal support and new approach may provide a fresh perspective.
AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders
UH Harrington Discovery Institute included in partnership to create and fund new gene therapy company focused on inhaled gene therapy to treat rare respiratory diseases.
Key Mechanisms of Airway Relaxation in Asthma Revealed in New Study
Novel role for nitric oxide in treatment of asthma and other obstructive airway diseases detailed by team at University Hospitals and Case Western Reserve University.
UH Now Offering a Revolutionary Treatment Option for Patients with Severe COPD/Emphysema
Zephyr lung valve is the first FDA-approved device to help emphysema patients breathe easier without major surgery.
Athersys and UH Announce Activation of First Clinical Site for MACOVIA Study, a Pivotal Phase 2/3 Study Evaluating Multistem® Cell Therapy for COVID-19 Induced ARDS
University Hospitals Cleveland Medical Center, a nationally ranked hospital, is ready to start screening patients.